{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T02:43:00Z","timestamp":1792204980686,"version":"4.4.0"},"reference-count":58,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2025,11,18]],"date-time":"2025-11-18T00:00:00Z","timestamp":1763424000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,11,18]],"date-time":"2025-11-18T00:00:00Z","timestamp":1763424000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neurosci. Bull."],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1007\/s12264-025-01543-9","type":"journal-article","created":{"date-parts":[[2025,11,18]],"date-time":"2025-11-18T14:42:05Z","timestamp":1763476925000},"page":"1079-1094","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Agomelatine Targets Aquaporin-4 Polarization to Rescue Glymphatic Dysfunction in Parkinson\u2019s Disease"],"prefix":"10.1007","volume":"42","author":[{"given":"Shisi","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dan","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guoming","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lu","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuehong","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xu","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhuang","family":"Kang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yiwei","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jialu","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4059-4627","authenticated-orcid":false,"given":"Wei","family":"Cai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2118-0368","authenticated-orcid":false,"given":"Zhengqi","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0043-7600","authenticated-orcid":false,"given":"Lei","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,11,18]]},"reference":[{"key":"1543_CR1","doi-asserted-by":"publisher","first-page":"596","DOI":"10.2174\/1871527320666211006142100","volume":"21","author":"S Kumar","year":"2022","unstructured":"Kumar S, Goyal L, Singh S. Tremor and rigidity in patients with Parkinson\u2019s disease: Emphasis on epidemiology, pathophysiology and contributing factors. CNS Neurol Disord Drug Targets 2022, 21: 596\u2013609.","journal-title":"CNS Neurol Disord Drug Targets"},{"key":"1543_CR2","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.cger.2019.08.002","volume":"36","author":"DK Simon","year":"2020","unstructured":"Simon DK, Tanner CM, Brundin P. Parkinson disease epidemiology, pathology, genetics, and pathophysiology. Clin Geriatr Med 2020, 36: 1\u201312.","journal-title":"Clin Geriatr Med"},{"key":"1543_CR3","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1007\/s11910-022-01223-5","volume":"22","author":"Z Xu","year":"2022","unstructured":"Xu Z, Anderson KN, Pavese N. Longitudinal studies of sleep disturbances in Parkinson\u2019s disease. Curr Neurol Neurosci Rep 2022, 22: 635\u2013655.","journal-title":"Curr Neurol Neurosci Rep"},{"key":"1543_CR4","first-page":"BR61","volume":"16","author":"N Adi","year":"2010","unstructured":"Adi N, Mash DC, Ali Y, Singer C, Shehadeh L, Papapetropoulos S. Melatonin MT1 and MT2 receptor expression in Parkinson\u2019s disease. Med Sci Monit 2010, 16: BR61\u2013BR67.","journal-title":"Med Sci Monit"},{"key":"1543_CR5","doi-asserted-by":"publisher","DOI":"10.3389\/fnagi.2021.736026","volume":"13","author":"T Li","year":"2021","unstructured":"Li T, Cheng C, Jia C, Leng Y, Qian J, Yu H. Peripheral clock system abnormalities in patients with Parkinson\u2019s disease. Front Aging Neurosci 2021, 13: 736026.","journal-title":"Front Aging Neurosci"},{"key":"1543_CR6","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1016\/j.sleep.2020.07.043","volume":"75","author":"H Kataoka","year":"2020","unstructured":"Kataoka H, Saeki K, Kurumatani N, Sugie K, Obayashi K. Melatonin secretion in patients with Parkinson\u2019s disease receiving different-dose levodopa therapy. Sleep Med 2020, 75: 309\u2013314.","journal-title":"Sleep Med"},{"key":"1543_CR7","doi-asserted-by":"publisher","first-page":"147ra111","DOI":"10.1126\/scitranslmed.3003748","volume":"4","author":"JJ Iliff","year":"2012","unstructured":"Iliff JJ, Wang M, Liao Y, Plogg BA, Peng W, Gundersen GA, et al. A paravascular pathway facilitates CSF flow through the brain parenchyma and the clearance of interstitial solutes, including amyloid \u03b2. Sci Transl Med 2012, 4: 147ra111.","journal-title":"Sci Transl Med"},{"key":"1543_CR8","doi-asserted-by":"publisher","first-page":"2583","DOI":"10.1007\/s11064-015-1581-6","volume":"40","author":"NA Jessen","year":"2015","unstructured":"Jessen NA, Munk AS, Lundgaard I, Nedergaard M. The glymphatic system: A beginner\u2019s guide. Neurochem Res 2015, 40: 2583\u20132599.","journal-title":"Neurochem Res"},{"key":"1543_CR9","doi-asserted-by":"publisher","first-page":"6365","DOI":"10.1523\/JNEUROSCI.1974-18.2019","volume":"39","author":"KN Mortensen","year":"2019","unstructured":"Mortensen KN, Sanggaard S, Mestre H, Lee H, Kostrikov S, Xavier ALR, et al. Impaired glymphatic transport in spontaneously hypertensive rats. J Neurosci 2019, 39: 6365\u20136377.","journal-title":"J Neurosci"},{"key":"1543_CR10","doi-asserted-by":"publisher","first-page":"1973","DOI":"10.4103\/1673-5374.390970","volume":"19","author":"Y Yue","year":"2024","unstructured":"Yue Y, Zhang X, Lv W, Lai HY, Shen T. Interplay between the glymphatic system and neurotoxic proteins in Parkinson\u2019s disease and related disorders: Current knowledge and future directions. Neural Regen Res 2024, 19: 1973\u20131980.","journal-title":"Neural Regen Res"},{"key":"1543_CR11","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1126\/science.abb8739","volume":"370","author":"M Nedergaard","year":"2020","unstructured":"Nedergaard M, Goldman SA. Glymphatic failure as a final common pathway to dementia. Science 2020, 370: 50\u201356.","journal-title":"Science"},{"key":"1543_CR12","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1146\/annurev-pathol-051217-111018","volume":"13","author":"BA Plog","year":"2018","unstructured":"Plog BA, Nedergaard M. The Glymphatic system in central nervous system health and disease: Past, present, and future. Annu Rev Pathol 2018, 13: 379\u2013394.","journal-title":"Annu Rev Pathol"},{"key":"1543_CR13","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1007\/s11940-016-0433-2","volume":"18","author":"Y Jung","year":"2016","unstructured":"Jung Y, St Louis EK. Treatment of REM Sleep Behavior Disorder. Curr Treat Options Neurol 2016, 18: 50.","journal-title":"Curr Treat Options Neurol"},{"key":"1543_CR14","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1177\/1756285611406166","volume":"4","author":"V Srinivasan","year":"2011","unstructured":"Srinivasan V, Cardinali DP, Srinivasan US, Kaur C, Brown GM, Spence DW, et al. Therapeutic potential of melatonin and its analogs in Parkinson\u2019s disease: focus on sleep and neuroprotection. Ther Adv Neurol Disord 2011, 4: 297\u2013317.","journal-title":"Ther Adv Neurol Disord"},{"key":"1543_CR15","doi-asserted-by":"publisher","first-page":"1591","DOI":"10.1002\/mds.26424","volume":"30","author":"RB Postuma","year":"2015","unstructured":"Postuma RB, Berg D, Stern M, Poewe W, Warren Olanow C, Oertel W, et al. MDS clinical diagnostic criteria for Parkinson\u2019s disease. Mov Disord 2015, 30: 1591\u20131601.","journal-title":"Mov Disord"},{"key":"1543_CR16","first-page":"422","volume":"21","author":"M Mustapha","year":"2021","unstructured":"Mustapha M, Mat Taib CN. MPTP-induced mouse model of Parkinson\u2019s disease: A promising direction of therapeutic strategies. Bosn J Basic Med Sci 2021, 21: 422\u2013433.","journal-title":"Bosn J Basic Med Sci"},{"key":"1543_CR17","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1038\/nprot.2006.342","volume":"2","author":"V Jackson-Lewis","year":"2007","unstructured":"Jackson-Lewis V, Przedborski S. Protocol for the MPTP mouse model of Parkinson\u2019s disease. Nat Protoc 2007, 2: 141\u2013151.","journal-title":"Nat Protoc"},{"key":"1543_CR18","doi-asserted-by":"publisher","first-page":"2576","DOI":"10.1093\/brain\/awaa179","volume":"143","author":"IF Harrison","year":"2020","unstructured":"Harrison IF, Ismail O, Machhada A, Colgan N, Ohene Y, Nahavandi P, et al. Impaired glymphatic function and clearance of tau in an Alzheimer\u2019s disease model. Brain 2020, 143: 2576\u20132593.","journal-title":"Brain"},{"key":"1543_CR19","doi-asserted-by":"publisher","first-page":"1487","DOI":"10.1177\/0271678X241260100","volume":"44","author":"S Wang","year":"2024","unstructured":"Wang S, Li C, Kang X, Su X, Liu Y, Wang Y, et al. Agomelatine promotes differentiation of oligodendrocyte precursor cells and preserves white matter integrity after cerebral ischemic stroke. J Cereb Blood Flow Metab 2024, 44: 1487\u20131500.","journal-title":"J Cereb Blood Flow Metab"},{"key":"1543_CR20","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.lfs.2018.03.022","volume":"200","author":"J Jang","year":"2018","unstructured":"Jang J, Chung S, Choi Y, Lim HY, Son Y, Chun SK, et al. The cryptochrome inhibitor KS15 enhances E-box-mediated transcription by disrupting the feedback action of a circadian transcription-repressor complex. Life Sci 2018, 200: 49\u201355.","journal-title":"Life Sci"},{"key":"1543_CR21","doi-asserted-by":"crossref","unstructured":"Schildge S, Bohrer C, Beck K, Schachtrup C. Isolation and culture of mouse cortical astrocytes. J Vis Exp 2013: 50079.","DOI":"10.3791\/50079"},{"key":"1543_CR22","doi-asserted-by":"publisher","first-page":"2280","DOI":"10.1038\/s41418-023-01216-y","volume":"30","author":"SY Jiang","year":"2023","unstructured":"Jiang SY, Tian T, Yao H, Xia XM, Wang C, Cao L, et al. The cGAS-STING-YY1 axis accelerates progression of neurodegeneration in a mouse model of Parkinson\u2019s disease via LCN2-dependent astrocyte senescence. Cell Death Differ 2023, 30: 2280\u20132292.","journal-title":"Cell Death Differ"},{"key":"1543_CR23","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1002\/ana.24271","volume":"76","author":"BT Kress","year":"2014","unstructured":"Kress BT, Iliff JJ, Xia M, Wang M, Wei HS, Zeppenfeld D, et al. Impairment of paravascular clearance pathways in the aging brain. Ann Neurol 2014, 76: 845\u2013861.","journal-title":"Ann Neurol"},{"key":"1543_CR24","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1001\/jamaneurol.2016.4370","volume":"74","author":"DM Zeppenfeld","year":"2017","unstructured":"Zeppenfeld DM, Simon M, Douglas Haswell J, D\u2019Abreo D, Murchison C, Quinn JF, et al. Association of perivascular localization of aquaporin-4 with cognition and Alzheimer disease in aging brains. JAMA Neurol 2017, 74: 91\u201399.","journal-title":"JAMA Neurol"},{"key":"1543_CR25","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1007\/s12264-021-00772-y","volume":"38","author":"J Cao","year":"2022","unstructured":"Cao J, Yao D, Li R, Guo X, Hao J, Xie M, et al. Digoxin ameliorates glymphatic transport and cognitive impairment in a mouse model of chronic cerebral hypoperfusion. Neurosci Bull 2022, 38: 181\u2013199.","journal-title":"Neurosci Bull"},{"key":"1543_CR26","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1038\/s41398-023-02614-z","volume":"13","author":"D Yao","year":"2023","unstructured":"Yao D, Li R, Hao J, Huang H, Wang X, Ran L, et al. Melatonin alleviates depression-like behaviors and cognitive dysfunction in mice by regulating the circadian rhythm of AQP4 polarization. Transl Psychiatry 2023, 13: 310.","journal-title":"Transl Psychiatry"},{"key":"1543_CR27","doi-asserted-by":"publisher","first-page":"2955","DOI":"10.1016\/j.celrep.2019.02.050","volume":"26","author":"AS Munk","year":"2019","unstructured":"Munk AS, Wang W, B\u00e8chet NB, Eltanahy AM, Cheng AX, Sigurdsson B, et al. PDGF-B is required for development of the glymphatic system. Cell Rep 2019, 26: 2955-2969.e3.","journal-title":"Cell Rep"},{"key":"1543_CR28","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1083\/jcb.201308118","volume":"204","author":"AJ Smith","year":"2014","unstructured":"Smith AJ, Jin BJ, Ratelade J, Verkman AS. Aggregation state determines the localization and function of M1- and M23-aquaporin-4 in astrocytes. J Cell Biol 2014, 204: 559\u2013573.","journal-title":"J Cell Biol"},{"key":"1543_CR29","doi-asserted-by":"publisher","first-page":"3860","DOI":"10.1016\/j.celrep.2019.05.097","volume":"27","author":"S Ciappelloni","year":"2019","unstructured":"Ciappelloni S, Bouchet D, Dubourdieu N, Bou\u00e9-Grabot E, Kellermayer B, Manso C, et al. Aquaporin-4 surface trafficking regulates astrocytic process motility and synaptic activity in health and autoimmune disease. Cell Rep 2019, 27: 3860-3872.e4.","journal-title":"Cell Rep"},{"key":"1543_CR30","doi-asserted-by":"publisher","first-page":"4411","DOI":"10.1038\/s41467-020-18115-2","volume":"11","author":"LM Hablitz","year":"2020","unstructured":"Hablitz LM, Pl\u00e1 V, Giannetto M, Vinitsky HS, St\u00e6ger FF, Metcalfe T, et al. Circadian control of brain glymphatic and lymphatic fluid flow. Nat Commun 2020, 11: 4411.","journal-title":"Nat Commun"},{"key":"1543_CR31","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0097423","volume":"9","author":"W Zhu","year":"2014","unstructured":"Zhu W, Gao Y, Chang CF, Wan JR, Zhu SS, Wang J. Mouse models of intracerebral hemorrhage in ventricle, cortex, and hippocampus by injections of autologous blood or collagenase. PLoS One 2014, 9: e97423.","journal-title":"PLoS One"},{"key":"1543_CR32","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1186\/s13041-019-0492-x","volume":"12","author":"J Peng","year":"2019","unstructured":"Peng J, Liu Y, Umpierre AD, Xie M, Tian DS, Richardson JR, et al. Microglial P2Y12 receptor regulates ventral hippocampal CA1 neuronal excitability and innate fear in mice. Mol Brain 2019, 12: 71.","journal-title":"Mol Brain"},{"key":"1543_CR33","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1016\/j.bbr.2008.11.004","volume":"198","author":"CL MacLellan","year":"2009","unstructured":"MacLellan CL, Langdon KD, Churchill KP, Granter-Button S, Corbett D. Assessing cognitive function after intracerebral hemorrhage in rats. Behav Brain Res 2009, 198: 321\u2013328.","journal-title":"Behav Brain Res"},{"key":"1543_CR34","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1007\/s12264-022-00936-4","volume":"39","author":"CY He","year":"2023","unstructured":"He CY, Tian DY, Chen SH, Jin WS, Cheng Y, Xin JY, et al. Elevated levels of naturally-occurring autoantibodies against the extracellular domain of p75NTR aggravate the pathology of Alzheimer\u2019s disease. Neurosci Bull 2023, 39: 261\u2013272.","journal-title":"Neurosci Bull"},{"key":"1543_CR35","doi-asserted-by":"publisher","first-page":"1543","DOI":"10.1152\/physrev.00011.2013","volume":"93","author":"EA Nagelhus","year":"2013","unstructured":"Nagelhus EA, Ottersen OP. Physiological roles of aquaporin-4 in brain. Physiol Rev 2013, 93: 1543\u20131562.","journal-title":"Physiol Rev"},{"key":"1543_CR36","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1523\/JNEUROSCI.17-01-00171.1997","volume":"17","author":"S Nielsen","year":"1997","unstructured":"Nielsen S, Nagelhus EA, Amiry-Moghaddam M, Bourque C, Agre P, Ottersen OP. Specialized membrane domains for water transport in glial cells: High-resolution immunogold cytochemistry of aquaporin-4 in rat brain. J Neurosci 1997, 17: 171\u2013180.","journal-title":"J Neurosci"},{"key":"1543_CR37","doi-asserted-by":"publisher","first-page":"17948","DOI":"10.1523\/JNEUROSCI.1860-12.2012","volume":"32","author":"M Wang","year":"2012","unstructured":"Wang M, Iliff JJ, Liao Y, Chen MJ, Shinseki MS, Venkataraman A, et al. Cognitive deficits and delayed neuronal loss in a mouse model of multiple microinfarcts. J Neurosci 2012, 32: 17948\u201317960.","journal-title":"J Neurosci"},{"key":"1543_CR38","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2021.650597","volume":"12","author":"S P\u00e9rez-Lloret","year":"2021","unstructured":"P\u00e9rez-Lloret S, Cardinali DP. Melatonin as a chronobiotic and cytoprotective agent in Parkinson\u2019s disease. Front Pharmacol 2021, 12: 650597.","journal-title":"Front Pharmacol"},{"key":"1543_CR39","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1016\/j.neurol.2019.07.025","volume":"176","author":"M Gunata","year":"2020","unstructured":"Gunata M, Parlakpinar H, Acet HA. Melatonin: A review of its potential functions and effects on neurological diseases. Rev Neurol (Paris) 2020, 176: 148\u2013165.","journal-title":"Rev Neurol (Paris)"},{"key":"1543_CR40","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.brainres.2014.09.068","volume":"1593","author":"TB Bassani","year":"2014","unstructured":"Bassani TB, Gradowski RW, Zaminelli T, Barbiero JK, Santiago RM, Boschen SL, et al. Neuroprotective and antidepressant-like effects of melatonin in a rotenone-induced Parkinson\u2019s disease model in rats. Brain Res 2014, 1593: 95\u2013105.","journal-title":"Brain Res"},{"key":"1543_CR41","doi-asserted-by":"publisher","first-page":"3022","DOI":"10.3390\/ijms24033022","volume":"24","author":"J Tchekalarova","year":"2023","unstructured":"Tchekalarova J, Tzoneva R. Oxidative stress and aging as risk factors for Alzheimer\u2019s disease and Parkinson\u2019s disease: The role of the antioxidant melatonin. Int J Mol Sci 2023, 24: 3022.","journal-title":"Int J Mol Sci"},{"key":"1543_CR42","doi-asserted-by":"publisher","DOI":"10.1096\/fj.202002718RR","volume":"35","author":"L Liu","year":"2021","unstructured":"Liu L, Cao Q, Gao W, Li BY, Zeng C, Xia Z, et al. Melatonin ameliorates cerebral ischemia-reperfusion injury in diabetic mice by enhancing autophagy via the SIRT1-BMAL1 pathway. FASEB J 2021, 35: e22040.","journal-title":"FASEB J"},{"key":"1543_CR43","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1097\/JCP.0000000000000404","volume":"35","author":"A Avila","year":"2015","unstructured":"Avila A, Cardona X, Martin-Baranera M, Leon L, Caballol N, Millet P, et al. Agomelatine for depression in parkinson disease: Additional effect on sleep and motor dysfunction. J Clin Psychopharmacol 2015, 35: 719\u2013723.","journal-title":"J Clin Psychopharmacol"},{"key":"1543_CR44","doi-asserted-by":"publisher","first-page":"434","DOI":"10.2174\/1570159X14666161228122115","volume":"15","author":"S Tordjman","year":"2017","unstructured":"Tordjman S, Chokron S, Delorme R, Charrier A, Bellissant E, Jaafari N, et al. Melatonin: Pharmacology, functions and therapeutic benefits. Curr Neuropharmacol 2017, 15: 434\u2013443.","journal-title":"Curr Neuropharmacol"},{"key":"1543_CR45","doi-asserted-by":"publisher","DOI":"10.1016\/j.nbd.2023.106035","volume":"179","author":"S Peng","year":"2023","unstructured":"Peng S, Liu J, Liang C, Yang L, Wang G. Aquaporin-4 in glymphatic system, and its implication for central nervous system disorders. Neurobiol Dis 2023, 179: 106035.","journal-title":"Neurobiol Dis"},{"key":"1543_CR46","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1093\/brain\/awab311","volume":"145","author":"MM Salman","year":"2022","unstructured":"Salman MM, Kitchen P, Halsey A, Wang MX, T\u00f6rnroth-Horsefield S, Conner AC, et al. Emerging roles for dynamic aquaporin-4 subcellular relocalization in CNS water homeostasis. Brain 2022, 145: 64\u201375.","journal-title":"Brain"},{"key":"1543_CR47","doi-asserted-by":"publisher","first-page":"2209","DOI":"10.1007\/s12035-023-03212-2","volume":"60","author":"Y Zhang","year":"2023","unstructured":"Zhang Y, Zhang C, He XZ, Li ZH, Meng JC, Mao RT, et al. Interaction between the glymphatic system and \u03b1-synuclein in Parkinson\u2019s disease. Mol Neurobiol 2023, 60: 2209\u20132222.","journal-title":"Mol Neurobiol"},{"key":"1543_CR48","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/s40035-019-0147-y","volume":"8","author":"W Zou","year":"2019","unstructured":"Zou W, Pu T, Feng W, Lu M, Zheng Y, Du R, et al. Blocking meningeal lymphatic drainage aggravates Parkinson\u2019s disease-like pathology in mice overexpressing mutated \u03b1-synuclein. Transl Neurodegener 2019, 8: 7.","journal-title":"Transl Neurodegener"},{"key":"1543_CR49","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1186\/s13195-022-00999-5","volume":"14","author":"M Simon","year":"2022","unstructured":"Simon M, Wang MX, Ismail O, Braun M, Schindler AG, Reemmer J, et al. Loss of perivascular aquaporin-4 localization impairs glymphatic exchange and promotes amyloid \u03b2 plaque formation in mice. Alzheimers Res Ther 2022, 14: 59.","journal-title":"Alzheimers Res Ther"},{"key":"1543_CR50","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1007\/s12017-012-8214-x","volume":"15","author":"A Hayashi","year":"2013","unstructured":"Hayashi A, Matsunaga N, Okazaki H, Kakimoto K, Kimura Y, Azuma H, et al. A disruption mechanism of the molecular clock in a MPTP mouse model of Parkinson\u2019s disease. Neuromolecular Med 2013, 15: 238\u2013251.","journal-title":"Neuromolecular Med"},{"key":"1543_CR51","doi-asserted-by":"publisher","first-page":"1085","DOI":"10.4103\/0366-6999.204920","volume":"130","author":"SY Li","year":"2017","unstructured":"Li SY, Wang YL, Liu WW, Lyu DJ, Wang F, Mao CJ, et al. Long-term levodopa treatment accelerates the circadian rhythm dysfunction in a 6-hydroxydopamine rat model of Parkinson\u2019s disease. Chin Med J (Engl) 2017, 130: 1085\u20131092.","journal-title":"Chin Med J (Engl)"},{"key":"1543_CR52","doi-asserted-by":"publisher","first-page":"131","DOI":"10.3389\/fnmol.2017.00131","volume":"10","author":"C Huang","year":"2017","unstructured":"Huang C, Zhu L, Li H, Shi FG, Wang GQ, Wei YZ, et al. Adulthood exposure to lipopolysaccharide exacerbates the neurotoxic and inflammatory effects of rotenone in the substantia nigra. Front Mol Neurosci 2017, 10: 131.","journal-title":"Front Mol Neurosci"},{"key":"1543_CR53","doi-asserted-by":"publisher","first-page":"6570","DOI":"10.1096\/fj.201901565RR","volume":"34","author":"WW Liu","year":"2020","unstructured":"Liu WW, Wei SZ, Huang GD, Liu LB, Gu C, Shen Y, et al. BMAL1 regulation of microglia-mediated neuroinflammation in MPTP-induced Parkinson\u2019s disease mouse model. FASEB J 2020, 34: 6570\u20136581.","journal-title":"FASEB J"},{"key":"1543_CR54","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2020.110887","volume":"132","author":"Y Li","year":"2020","unstructured":"Li Y, Zhang J, Wan J, Liu A, Sun J. Melatonin regulates A\u03b2 production\/clearance balance and A\u03b2 neurotoxicity: A potential therapeutic molecule for Alzheimer\u2019s disease. Biomed Pharmacother 2020, 132: 110887.","journal-title":"Biomed Pharmacother"},{"key":"1543_CR55","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2020.110485","volume":"129","author":"DL Delgado-Lara","year":"2020","unstructured":"Delgado-Lara DL, Gonz\u00e1lez-Enr\u00edquez GV, Torres-Mendoza BM, Gonz\u00e1lez-Usigli H, C\u00e1rdenas-Bedoya J, Mac\u00edas-Islas MA, et al. Effect of melatonin administration on the PER1 and BMAL1 clock genes in patients with Parkinson\u2019s disease. Biomed Pharmacother 2020, 129: 110485.","journal-title":"Biomed Pharmacother"},{"key":"1543_CR56","doi-asserted-by":"publisher","first-page":"19082","DOI":"10.1038\/s41598-019-55663-0","volume":"9","author":"MC Beker","year":"2019","unstructured":"Beker MC, Caglayan B, Caglayan AB, Kelestemur T, Yalcin E, Caglayan A, et al. Interaction of melatonin and Bmal1 in the regulation of PI3K\/AKT pathway components and cellular survival. Sci Rep 2019, 9: 19082.","journal-title":"Sci Rep"},{"key":"1543_CR57","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1126\/science.1172156","volume":"326","author":"KA Lamia","year":"2009","unstructured":"Lamia KA, Sachdeva UM, DiTacchio L, Williams EC, Alvarez JG, Egan DF, et al. AMPK regulates the circadian clock by cryptochrome phosphorylation and degradation. Science 2009, 326: 437\u2013440.","journal-title":"Science"},{"key":"1543_CR58","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbabio.2020.148157","volume":"1861","author":"SP Rao","year":"2020","unstructured":"Rao SP, Sharma N, Kalivendi SV. Embelin averts MPTP-induced dysfunction in mitochondrial bioenergetics and biogenesis via activation of SIRT1. Biochim Biophys Acta Bioenerg 2020, 1861: 148157.","journal-title":"Biochim Biophys Acta Bioenerg"}],"container-title":["Neuroscience Bulletin"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12264-025-01543-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12264-025-01543-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12264-025-01543-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,11]],"date-time":"2026-05-11T04:28:47Z","timestamp":1778473727000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12264-025-01543-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,18]]},"references-count":58,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026,5]]}},"alternative-id":["1543"],"URL":"https:\/\/doi.org\/10.1007\/s12264-025-01543-9","relation":{},"ISSN":["1673-7067","1995-8218"],"issn-type":[{"value":"1673-7067","type":"print"},{"value":"1995-8218","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,18]]},"assertion":[{"value":"25 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 July 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Authors declare that they have no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}}]}}